Journey Medical Corp
For the period ended Jun 24, 2025. Filed Jun 26, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Jun 24, 2025 · Filed Jun 26, 2025
Use the contents to explore the available documents and sections.
Contents
Proposal
Proposal 1
The votes with respect to the election of six directors to hold office until the 2026 annual meeting of stockholders were as follows:
| Director | Votes For | Votes Withheld | Broker Non-Votes |
|---|---|---|---|
| Lindsay A. Rosenwald, M.D. | 25,498,701 | 684,668 | 6,319,771 |
| Claude Maraoui | 25,713,887 | 469,482 | 6,319,771 |
| Neil Herskowitz | 25,428,625 | 754,744 | 6,319,771 |
| Justin Smith | 25,689,779 | 493,590 | 6,319,771 |
| Miranda Toledano | 25,652,600 | 530,769 | 6,319,771 |
| Michael Pearce | 26,070,024 | 113,345 | 6,319,771 |
Proposal 2
The vote with respect to the ratification of KPMG LLP as Journey’s independent registered accounting firm for the year ending December 31, 2025 was as follows:
| Total Votes For | Total Votes Against | Abstentions |
|---|---|---|
| 32,468,451 | 10,433 | 24,256 |
Proposal 3
The vote with respect to the approval of the Fourth Amended and Restated Charter to provide for, among other things, officer exculpation, was as follows:
| Total Votes For | Total Votes Against | Abstentions | Broker Non-Votes |
|---|---|---|---|
| 25,373,988 | 798,994 | 10,387 | 6,319,771 |
| Item 9.01. | Financial Statements and Exhibits. |
|---|
(d) Exhibits.
The following exhibits are furnished herewith:
| Exhibit Number | Description |
| 3.1 | Fourth Amended and Restated Certificate of Incorporation, filed June 24, 2025 |
| 104 | Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL). |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.